CONDITION
Osteosarcoma
Osteosarcoma represents an aggressive bone cancer most commonly affecting the limbs of large and giant breed dogs, often presenting with progressive lameness.
Why this matters now
Osteosarcoma typically develops in middle-aged to older large breed dogs, though it can appear in younger animals. The condition often presents when owners notice lameness that persists or keeps returning, prompting further investigation.
This cancer tends to progress locally within the bone while also having high potential for spread to distant sites, particularly the lungs. Early lameness may worsen over weeks to months, and pathological fractures can occur as the tumour weakens bone structure.
Signals & patterns
Early signals
Intermittent limb lameness
Initial lameness may come and go, sometimes improving briefly before returning.
Reluctance to bear weight
Dogs may shift weight away from the affected limb, particularly after rest.
Subtle swelling near joints
Slight enlargement around the wrist, shoulder, or knee area may develop.
Reduced activity
Previously active dogs may show decreased enthusiasm for walks or play.
Later signals
Persistent, worsening lameness
Lameness becomes constant and progressively more severe.
Visible bony swelling
A firm mass may become apparent at the tumour site.
Pathological fracture
The weakened bone may fracture with minimal trauma, usually seen as a sudden, severe worsening of lameness, often with the leg not used at all.
General decline
Lethargy, reduced appetite, and weight loss may accompany advanced disease.
Click to read about the biological mechanisms
How this is usually investigated
Investigation combines imaging to characterise the bone lesion with staging tests to assess for spread, informing prognosis and treatment options.
Radiographs of affected limb
Chest radiographs
Bone biopsy
CT scan
Blood work
Options & trade-offs
Treatment approaches range from amputation with chemotherapy, which gives the longest survival but rarely a cure, to palliative care focused on comfort, with choice depending on tumour characteristics and individual circumstances.
Amputation with chemotherapy
Removal of affected limb followed by systemic treatment to address microscopic spread
Trade-offs: Published median survival with chemotherapy after amputation is 8 to 14 months, compared with 3 to 4 months after amputation alone; most dogs adapt well to three legs; chemotherapy is generally well tolerated. No chemotherapy drug is UK-authorised for this use in dogs, so it is given under the veterinary medicines cascade.
Limb-sparing surgery
Removal of tumour while preserving the limb using bone grafts or implants
Trade-offs: Maintains limb function; technically demanding; higher complication rate; not suitable for all locations.
Radiation therapy
Palliative radiation to reduce pain and slow tumour progression
Trade-offs: Provides pain relief for weeks to months; does not address spread; multiple sessions required.
Pain management alone
Focus on maintaining comfort through medications without addressing the tumour
Trade-offs: Appropriate when other options are declined or unsuitable; provides quality time, but for a limited period, as most untreated dogs survive only 1 to 2 months.
Bisphosphonate therapy
Medications that may reduce bone pain and slow local destruction
Trade-offs: Can complement other treatments; some evidence for pain benefit; does not address underlying cancer. The bisphosphonates used in dogs are human medicines, given under the veterinary medicines cascade.
Common misconceptions
"Dogs cannot cope with three legs"
Most dogs adapt well to amputation and are usually walking within 24 hours of surgery, and good mobility has been reported even in large and giant breeds. Amputation is less suitable for dogs with significant orthopaedic or neurological problems in the remaining legs.
"Osteosarcoma only affects very old dogs"
While most common in middle-aged to older large and giant breed dogs, osteosarcoma also shows a small first peak in young dogs aged 18 to 24 months, so age alone should not rule it out.
"A limp that improves rules out bone cancer"
Osteosarcoma-related lameness can wax and wane initially and often improves for a time with anti-inflammatory painkillers, which can lead to it being mistaken for a joint or soft tissue injury and delay diagnosis.
Related conditions
Osteoarthritis in Dogs
Osteoarthritis is a common cause of lameness in older large-breed dogs. Early osteosarcoma lameness often improves for a time with anti-inflammatory painkillers, so it can at first be attributed to arthritis, and in some cases lameness put down to arthritis later proves to reflect an underlying bone tumour.
Osteochondritis Dissecans (OCD)
Osteochondritis dissecans typically presents in young, growing dogs of large or giant breeds with lameness localised to a specific joint. Osteosarcoma also affects large-breed dogs but tends to occur later in life; both conditions can cause progressive limb pain, and distinguishing between them may require imaging that characterises the bone and joint structures involved.
Obesity in Dogs
Body weight has been studied as a risk factor: dogs at or above the mean weight for their breed have been reported as 1.65 times as likely to develop osteosarcoma, though the relationship with obesity itself remains incompletely understood. Excess weight can also complicate post-operative recovery and adaptation after limb amputation or other surgical intervention.
Owners of large breed dogs noticing lameness that persists, returns after improving, or comes with a firm swelling over a limb bone may wish to explore diagnostic options sooner rather than later. Understanding the range of available approaches can help in considering how to balance quality and duration of life.
Last reviewed: 9 October 2026 · Dr Alastair Greenway MRCVS